Jimcel
Crippling meth addict
- Joined
- Jan 4, 2026
- Posts
- 4,991
- Reputation
- 6,087
What Actually Works for ENHANCED STUDYING - An Advanced Guide to Nootropics ** With STUDIES* *
Disclaimer: This is for educational purposes only. Consult a Doctor before using, especially if you have medical conditions or take other medications.
Disclaimer: This is for educational purposes only. Consult a Doctor before using, especially if you have medical conditions or take other medications.
Semax
Synthetic ACTH(4-10) peptide analog used for cognitive support and recovery from mental fatigue or hypoxia. Helps sustain attention and short-term memory.
Mechanism:
Mechanism:
Semax lacks the hormonal activity of full ACTH. It upregulates brain-derived neurotrophic factor (BDNF) and its receptor TrkB in the hippocampus and cortex, increasing BDNF protein and mRNA within hours in animal models. It also modulates dopaminergic and serotonergic turnover (raising metabolite levels and amplifying responses to stimulants), produces nootropic EEG changes (increased alpha power, reduced delta), and exerts antihypoxic effects. The C-terminal Pro-Gly-Pro extension contributes to stability and CNS delivery via the intranasal route, which preferentially targets forebrain structures relevant to attention and memory.
“Nootropic properties of ACTH4-10 analogue, Semax, were demonstrated in experiments with human volunteers. The antihypoxic effect of Semax was shown by EEG analysis after short-term hyperventilation. Semax induced changes in the EEG similar to those seen after administration of typical nootropic drugs. Particularly important was the long-term (20-24 h) beneficial action of Semax on the work efficiency of operators after intranasal administration of 0.25−1.0 mg of the peptide (about 4.0 − 16.0 μg/kg body weight).”
Dosing/protocol:
200–600 mcg intranasal
1–3 times daily (morning and midday preferred)
Typical course: 10–14 days, followed by a break
Side effects:
Mild nasal irritation
Increased vivid dreaming
Occasional mild headache
Selank
Synthetic tuftsin analog with anxiolytic and mild pro-cognitive effects. Helps reduce anxiety and mental fatigue that impair focus and retention.
Mechanism:
Selank is an analog of the endogenous immunomodulatory peptide tuftsin. It inhibits enkephalin-degrading enzymes, prolonging the action of endogenous opioid peptides involved in natural anxiety regulation. It enhances GABAergic signaling indirectly (without binding the classic benzodiazepine site), increases serotonin turnover in multiple brain regions, and modestly elevates BDNF expression. The net profile is anxiolysis plus mild antiasthenic and psychostimulant effects, without the sedation, cognitive impairment, tolerance, or withdrawal typical of benzodiazepines. Effects on serum leu-enkephalin half-life correlate with clinical improvement in anxiety patients.
Study:https://pubmed.ncbi.nlm.nih.gov/18454096/
Mechanism:
Selank is an analog of the endogenous immunomodulatory peptide tuftsin. It inhibits enkephalin-degrading enzymes, prolonging the action of endogenous opioid peptides involved in natural anxiety regulation. It enhances GABAergic signaling indirectly (without binding the classic benzodiazepine site), increases serotonin turnover in multiple brain regions, and modestly elevates BDNF expression. The net profile is anxiolysis plus mild antiasthenic and psychostimulant effects, without the sedation, cognitive impairment, tolerance, or withdrawal typical of benzodiazepines. Effects on serum leu-enkephalin half-life correlate with clinical improvement in anxiety patients.
Study:https://pubmed.ncbi.nlm.nih.gov/18454096/
“Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam (32 patients). Patient's state was assessed with psychometric scales (Hamilton, Zung, CGI). Enkephalin activity in the blood serum was measured as well. The anxiolytic effects of both drugs were similar but selank had also antiasthenic and psychostimulant effects. The clinical-biological study revealed that patients with GAD and neurasthenia had the decreased level of tau(1/2) leu-enkephalin which was correlated with disease duration, severity of symptoms related to anxiety and asthenia and autonomic disorders. The increase of this parameter and stronger positive correlations with anxiety level were observed during the treatment with selank mostly in patients with GAD.”
Dosing/protocol:
150–450 mcg intranasal
2–3 times daily
Typical course: 10–14 days with breaks
Side effects:
nasal irritation
drowsiness
mild headache
150–450 mcg intranasal
2–3 times daily
Typical course: 10–14 days with breaks
Side effects:
nasal irritation
drowsiness
mild headache
Noopept (Omberacetam)
Synthetic dipeptide-related nootropic. Improves memory and learning under cognitive demand.
Mechanism:
Noopept is metabolized in part to the endogenous cyclic dipeptide cycloprolylglycine, a higher-affinity AMPA receptor modulator than piracetam. It also increases expression of nerve growth factor (NGF) and BDNF in the hippocampus, activates alpha-7 nicotinic acetylcholine receptors, engages the HIF-1 pathway, and exerts antioxidant and anti-excitotoxic effects on glutamatergic systems. These actions support all phases of memory and provide neuroprotection.
Study:https://pubmed.ncbi.nlm.nih.gov/19234797/
Mechanism:
Noopept is metabolized in part to the endogenous cyclic dipeptide cycloprolylglycine, a higher-affinity AMPA receptor modulator than piracetam. It also increases expression of nerve growth factor (NGF) and BDNF in the hippocampus, activates alpha-7 nicotinic acetylcholine receptors, engages the HIF-1 pathway, and exerts antioxidant and anti-excitotoxic effects on glutamatergic systems. These actions support all phases of memory and provide neuroprotection.
Study:https://pubmed.ncbi.nlm.nih.gov/19234797/
Comparative open-label trial in patients with mild cognitive disorders of vascular or traumatic origin showed Noopept (20 mg/day) produced greater or comparable improvement on most cognitive and mood measures versus 1200 mg piracetam, with faster onset (day 7 vs day 14) and approximately 1.8-fold fewer side effects. MMSE scores improved from ~26 to 29 in the Noopept group; benefits were seen across vascular and post-traumatic subgroups.
Dosing/protocol:
10–20 mg per day Split into two doses (morning + early afternoon)
Can be taken after food
Side effects:
Increased blood pressure
Irritability or headache
Phenylpiracetam
Phenyl-substituted racetam with stimulant-like properties. Provides acute focus, motivation, and mental energy for demanding sessions.
Mechanism:
The added phenyl group markedly increases CNS penetration and adds dopaminergic/noradrenergic activity absent in piracetam. It acts as a positive allosteric modulator of AMPA receptors while increasing dopamine and norepinephrine signaling and upregulating dopamine receptor density (D1–D3) in striatal and prefrontal regions. This combination produces cleaner stimulation, enhanced motivation, physical performance support, and memory effects, but also leads to rapid tolerance with daily use.
Mechanism:
The added phenyl group markedly increases CNS penetration and adds dopaminergic/noradrenergic activity absent in piracetam. It acts as a positive allosteric modulator of AMPA receptors while increasing dopamine and norepinephrine signaling and upregulating dopamine receptor density (D1–D3) in striatal and prefrontal regions. This combination produces cleaner stimulation, enhanced motivation, physical performance support, and memory effects, but also leads to rapid tolerance with daily use.
Patients receiving 200 mg daily for 30 days showed significant improvement in motor coordination, higher brain function, memory, attention, and counting ability, along with reductions in anxiety and depression scores.
(Primary literature is largely Russian-language clinical reports; limited free English full-text availability.)
Dosing/protocol:
100–200 mg oral
Maximum 2–3 days per week
Morning or pre-session dosing preferred; full rest days required to limit tolerance
Side effects:
Insomnia
Irritability/overstimulation
Headache
Rapid tolerance with daily use
Bromantane
Actoprotector that raises endogenous dopamine synthesis capacity. Supports smooth motivation and stamina without classic stimulant crash or strong peripheral effects.
Mechanism:
Unlike reuptake inhibitors or releasers, bromantane upregulates gene expression of tyrosine hydroxylase (the rate-limiting enzyme converting tyrosine to L-DOPA) and aromatic L-amino acid decarboxylase (converting L-DOPA to dopamine). This increases the brain’s capacity to produce dopamine (and serotonin via related pathways) over hours to days in regions including striatum, hypothalamus, and nucleus accumbens. Mild GABAergic enhancement contributes anxiolytic effects. The result is gradual, sustained dopaminergic tone without rapid depletion, hyperstimulation, or marked dependence liability.
Study:https://pubmed.ncbi.nlm.nih.gov/21322821/
Mechanism:
Unlike reuptake inhibitors or releasers, bromantane upregulates gene expression of tyrosine hydroxylase (the rate-limiting enzyme converting tyrosine to L-DOPA) and aromatic L-amino acid decarboxylase (converting L-DOPA to dopamine). This increases the brain’s capacity to produce dopamine (and serotonin via related pathways) over hours to days in regions including striatum, hypothalamus, and nucleus accumbens. Mild GABAergic enhancement contributes anxiolytic effects. The result is gradual, sustained dopaminergic tone without rapid depletion, hyperstimulation, or marked dependence liability.
Study:https://pubmed.ncbi.nlm.nih.gov/21322821/
In 728 patients with asthenic disorders treated with 50–100 mg/day for 28 days, CGI-S responder rate was 76.0% and CGI-I responder rate was 90.8%. Anti-asthenic effects appeared by day 3 and persisted one month after discontinuation; adverse effects occurred in 3% of patients (0.8% discontinued); the authors concluded it is a highly effective, well-tolerated drug with a wide spectrum of clinical effects for asthenic disorders.
Dosing/protocol:
50–100 mg oral once daily (Morning dosing only)
Typical course: 2–4 weeks, with optional breaks
Side effects:
Mild restlessness at higher doses
Insomnia
Nausea or headache
Modafinil
Eugeroic that promotes wakefulness. Helps maintain alertness - especially under fatigue or sleep restriction.
Mechanism:
Primarily inhibits the dopamine transporter (weaker affinity than classic stimulants), increasing extracellular dopamine. Additional actions on orexin/hypocretin, histamine, and norepinephrine systems promote wakefulness with relatively lower abuse potential and less peripheral sympathomimetic activity than amphetamines. Effects on complex attention and executive function are more consistent than on basic memory tasks in non-sleep-deprived individuals.
Study: https://pubmed.ncbi.nlm.nih.gov/31433334/
Mechanism:
Primarily inhibits the dopamine transporter (weaker affinity than classic stimulants), increasing extracellular dopamine. Additional actions on orexin/hypocretin, histamine, and norepinephrine systems promote wakefulness with relatively lower abuse potential and less peripheral sympathomimetic activity than amphetamines. Effects on complex attention and executive function are more consistent than on basic memory tasks in non-sleep-deprived individuals.
Study: https://pubmed.ncbi.nlm.nih.gov/31433334/
“In conclusion, the available evidence indicates only limited potential for modafinil to act as a cognitive enhancer outside sleep-deprived populations.”
Dosing/protocol:
100–200 mg once daily
Morning only (long half-life)
Side effects:
Headache
Insomnia
Anxiety
Nausea/decreased appetite
Increased heart rate or blood pressure
Methylphenidate (Ritalin)
Catecholamine reuptake inhibitor. Improves memory, processing speed, and focus.
Mechanism:
Blocks dopamine and norepinephrine transporters, raising synaptic concentrations in the prefrontal cortex and striatum. This improves the signal-to-noise ratio in attention and executive networks. Low-to-moderate doses enhance performance; higher doses can produce overstimulation.
Study:https://pubmed.ncbi.nlm.nih.gov/22169884/
Mechanism:
Blocks dopamine and norepinephrine transporters, raising synaptic concentrations in the prefrontal cortex and striatum. This improves the signal-to-noise ratio in attention and executive networks. Low-to-moderate doses enhance performance; higher doses can produce overstimulation.
Study:https://pubmed.ncbi.nlm.nih.gov/22169884/
“To the best of our knowledge, this is the first study reporting enhanced declarative memory consolidation after methylphenidate in a dose-related fashion over a dose range that is presumed to reflect a wide range of dopamine reuptake inhibition.”
Dosing/protocol:
10–40 mg immediate-release (start low) dosed in morning
Side effects:
Appetite suppression
Insomnia
Increased heart rate/blood pressure
Anxiety
Example Protocol:
Morning: Semax 300–600 mcg IN + Selank 250–450 mcg IN + Noopept 10–20 mg Bromantane 50–100 mg
Occasional use: Phenylpiracetam 100–200 mg/ Modafinil 100–200 mg + nootropics listed above
Occasional use: Phenylpiracetam 100–200 mg/ Modafinil 100–200 mg + nootropics listed above
Adderall
Stimulant containing a 3:1 ratio of dextroamphetamine to levoamphetamine salts. Strongly supports sustained attention, motivation, processing speed, and task engagement, especially under high cognitive load or with ADHD. Frequently used for studying.
Mechanism:
Amphetamines both release and block reuptake of dopamine and norepinephrine. They enter neurons via the transporters (DAT/NET), reverse their direction, and promote efflux of catecholamines from synaptic vesicles via VMAT2 disruption and cytoplasmic release. This produces large increases in extracellular dopamine and norepinephrine in prefrontal cortex and striatum. The result is enhanced signal-to-noise ratio in attention networks, increased motivation via mesolimbic pathways, and improved executive control. Effects are dose-dependent and follow an inverted-U pattern: moderate doses improve focus; higher doses can cause overstimulation, tunnel vision, or anxiety. Tolerance develops with repeated use due to receptor downregulation and depletion of vesicular stores.
Study: https://pubmed.ncbi.nlm.nih.gov/22884611/
Mechanism:
Amphetamines both release and block reuptake of dopamine and norepinephrine. They enter neurons via the transporters (DAT/NET), reverse their direction, and promote efflux of catecholamines from synaptic vesicles via VMAT2 disruption and cytoplasmic release. This produces large increases in extracellular dopamine and norepinephrine in prefrontal cortex and striatum. The result is enhanced signal-to-noise ratio in attention networks, increased motivation via mesolimbic pathways, and improved executive control. Effects are dose-dependent and follow an inverted-U pattern: moderate doses improve focus; higher doses can cause overstimulation, tunnel vision, or anxiety. Tolerance develops with repeated use due to receptor downregulation and depletion of vesicular stores.
Study: https://pubmed.ncbi.nlm.nih.gov/22884611/
“The results did not reveal enhancement of any cognitive abilities by MAS for participants in general. There was a suggestion of moderation of enhancement by baseline ability and COMT genotype in a minority of tasks, with MAS enhancing lower ability participants on word recall, embedded figures and Raven’s Progressive Matrices. Despite the lack of enhancement observed for most measures and most participants, participants nevertheless believed their performance was more enhanced by the active capsule than by placebo. We conclude that MAS has no more than small effects on cognition in healthy young adults, although users may perceive the drug as enhancing their cognition.”
Dosing/protocol:
5–20 mg immediate-release (or equivalent XR)
Morning dosing only; avoid late-day use
Not intended for continuous daily use
Side effects:
Appetite suppression and weight loss
Insomnia
Increased heart rate and blood pressure
Anxiety, irritability, or jitteriness
Dry mouth
Potential for dependence
Conclusion:
These compounds can support focus, motivation, or anxiety control through various mechanisms. It is important to take things in moderation to eliminate any potential risks - using breaks and appropriate stacks will ensure this.
Last edited:

